Platelet count/bipolar spleen diameter ratio for the prediction of esophageal varices: The special Egyptian situation

Hepatitis Monthly

Volumn 11, Issue 4, 2011, Pages 278-284

  Abu El Makarem, Mona A ^a   Shatat, Mohamed E ^a   Shaker, Yehya ^a   Abdel Aleem, Ahmad A ^a   El Sherif, Ali M ^a   Moaty, Maysa Abdel ^a   Abdel Ghany, Hosny S ^a   Elakad, Atef ^a   Kamal Eldeen, Amal M ^a  

^a MINIA UNIVERSITY   (Egypt)

Author keywords

Bipolar disorders; Cirrhosis; Platelet count; Spleen

Indexed keywords

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EGYPT; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEPATOGRAPHY; HUMAN; LABORATORY TEST; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PREDICTION; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SPLEEN SIZE; THROMBOCYTE COUNT;

EID: 79961039822     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Schiedermaier P. Splanchnic hemodynamics: cirrhotic versus non-cirrhotic portal hypertension. J Gastroenterol Hepatol 2004;19(s7):S150-S4.
2. Hong WD, Zhu QH, Huang ZM, Chen XR, Jiang ZC, Xu SH, et al. Predictors of esophageal varices in patients with HBV-related cirrhosis: a retrospective study. BMC Gastroenterol. 2009;9:11.
3. Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology. 2002;122(6):1620-30.
4. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33(5):846-52.
5. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43(1):167-76.
6. Gorka W, al Mulla A, al Sebayel M, Altraif I, Gorka TS. Qualitative hepatic venous Doppler sonography versus portal fowmetry in predicting the severity of esophageal varices in hepatitis C cirrhosis. AJR Am J Roentgenol. 1997;169(2):511-5.
7. Lavergne J, Molina E, Reddy KR, Jefers L, Leon R, Nader AK, et al. Ascites predicts the presence of high grade varices by screening gastroscopy. Gastrointest Endosc. 1997;45(4):AB187.
8. Pilette C, Oberti F, Aube C, Rousselet MC, Bedossa P, Gallois Y, et al. Non-invasive diagnosis of esophageal varices in chronic liver diseases. J Hepatol. 1999;31(5):867-73.
9. Madhotra R, Mulcahy HE, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2002;34(1):81-5.
10. Schepis F, Camma C, Niceforo D, Magnano A, Pallio S, Cinquegra-ni M, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology. 2001;33(2):333-8.
11. Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Wilcox CM, et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol. 1999;94(11):3285-91.
12. Ng FH, Wong SY, Loo CK, Lam KM, Lai CW, Cheng CS. Prediction of oesophagogastric varices in patients with liver cirrhosis. J Gastroenterol Hepatol. 1999;14(8):785-90.
13. Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol. 1999;94(11):3292-6.
14. Zaman A, Becker T, Lapidus J, Benner K. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med. 2001;161(21):2564-70.
15. Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003;52(8):1200-5.
16. Peck-Radosavljevic M. Thrombocytopenia in liver disease. Can J Gastroenterol. 2000;14(Suppl D):60D-6D.
17. de Franchis R. Noninvasive diagnosis of esophageal varices: is it feasible? Am J Gastroenterol. 2006;101(11):2520-2.
18. Tchelepi H, Ralls P, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med. 2002;21(9):1023.
19. Lamb PM, Lund A, Kanagasabay RR, Martin A, Webb JA, Reznek RH. Spleen size: how well do linear ultrasound measurements correlate with three-dimensional CT volume assessments? Br J Radiol. 2002;75(895):573-7.
20. Moriyasu F, Ban N, Nishida O, Nakamura T, Miyake T, Uchino H, et al. Clinical application of an ultrasonic duplex system in the quantitative measurement of portal blood flow. J Clin Ultrasound. 1986;14(8):579-88.
21. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646-9.
22. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922-38.
23. EMOH. Egyptian Ministry of Health Annual Report: 2007: Egyptian Ministry of Health; 2009 March 6.
24. Attia MA. Prevalence of hepatitis B and C in Egypt and Africa. Antivir Ther. 1998;3(Suppl 3):1-9.
25. El-Zayadi AR. Curse of schistosomiasis on Egyptian liver. World J Gastroenterol. 2004;10(8):1079-81.
26. Mikhail NN, Lewis DL, Omar N, Taha H, El-Badawy A, Abdel-Mawgoud N, et al. Prospective study of cross-infection from up-per-GI endoscopy in a hepatitis C-prevalent population. Gastro-intest Endosc. 2007;65(4):584-8.
27. Burton JR, Liangpunsakul S, Lapidus J, Giannini E, Chalasani N, Zaman A. Validation of a multivariate model predicting presence and size of varices. J Clin Gastroenterol. 2007;41(6):609-15.
28. Garcia-Tsao G, Escorsell A, Zakko M, Patch D, Matlof D, Grace N, et al. Predicting the presence of significant portal hypertension and varices in compensated cirrhotic patients. Hepatology. 1997;26(pt 2):927-30.
29. Thomopoulos KC, Labropoulou-Karatza C, Mimidis KP, Katsakou-lis EC, Iconomou G, Nikolopoulou VN. Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Dig Liver Dis. 2003;35(7):473-8.
30. Berzigotti A, Gilabert R, Abraldes JG, Nicolau C, Bru C, Bosch J, et al. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am J Gastroenterol. 2008;103(5):1159-67.
31. Pagliaro L, D'Amico G, Pasta L, Politi F, Vizzini G, Traina M, et al. Portal hypertension in cirrhosis: natural history. Bosch J, Grosz-mann RJ Portal Hypertension Pathophysiology and Treatment Oxford, UK: Blackwell Scientifc. 1994:72-92.
32. Thabut D, Trabut JB, Massard J, Rudler M, Muntenau M, Messous D, et al. Non-invasive diagnosis of large oesophageal varices with Fibro Test in patients with cirrhosis: a preliminary retrospective study. Liver Int. 2006;26(3):271-8.
33. Kazemi F, Kettaneh A, N'Kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, et al. Liver stifness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol. 2006;45(2):230-5.
34. Li FH, Hao J, Xia JG, Li HL, Fang H. Hemodynamic analysis of esophageal varices in patients with liver cirrhosis using color Doppler ultrasound. World J Gastroenterol. 2005;11(29):4560-5.
35. Legasto GMA, Sevilla J, Balay A, Tan JA, Cham LV, Vitug A, et al. Platelet count/spleen diameter ratio: a noninvasive parameter to predict the presence of esophageal varices. Phil J Gastroenterol 2006;2:33-8.
36. Alempijevic T, Kovacevic N. Right liver lobe diameter: albumin ratio: a new non-invasive parameter for prediction of oesopha-geal varices in patients with liver cirrhosis (preliminary report). Gut. 2007;56(8):1166-7; author reply 7.
37. Agha A, Anwar E, Bashir K, Savarino V, Giannini EG. External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci. 2009;54(3):654-60.
38. Baig WW, Nagaraja MV, Varma M, Prabhu R. Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: Is it feasible? Can J Gastroenterol. 2008;22(10):825-8.
39. Bolognesi M, Merkel C, Sacerdoti D, Nava V, Gatta A. Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis. 2002;34(2):144-50.
40. Liangpunsakul S, Ulmer BJ, Chalasani N. Predictors and implications of severe hypersplenism in patients with cirrhosis. Am J Med Sci. 2003;326(3):111-6.
41. Pockros PJ, Duchini A, McMillan R, Nyberg LM, McHutchison J, Viernes E. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 2002;97(8):2040-5.
42. Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E, et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol. 2006;101(11):2511-9.
43. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208-36.
44. Winkfeld B, Aube C, Burtin P, Cales P. Inter-observer and intra-observer variability in hepatology. Eur J Gastroenterol Hepatol. 2003;15(9):959-66.
45. O'Donohue J, Ng C, Catnach S, Farrant P, Williams R. Diagnostic value of Doppler assessment of the hepatic and portal vessels and ultrasound of the spleen in liver disease. Eur J Gastroenterol Hepatol. 2004;16(2):147-55.
46. Ong J. Clinical predictors of large esophageal varices: how accurate are they? Am J Gastroenterol. 1999;94(11):3103-5.
47. Rajvanshi P, Kowdley KV. Prediction of varices in patients with cirrhosis: a high-stakes numbers game? J Clin Gastroenterol. 2002;34(1):4-5.